Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 601–700 of 999
Zhou, P., Zhang, W., Liao, Y., Zhai, Z., Lu, S., Jiang, S., Hu, W., & Gong, W. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002573 · Cited by 18
Enhanced metagenomic strategies for elucidating the complexities of gut microbiota: a review
Li, X., & Lu, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1626002 · Cited by 21
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptation
Coleman, O. I., Sorbie, A., Riva, A., von Stern, M., Kuhls, S., Selegato, D. M., Siegert, L., Keidel, I., Köhler, N., Wirbel, J., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01350-6 · Cited by 17
Pani, G. (2023) · Cancers · doi:10.3390/cancers15092583 · Cited by 17
“Coli, is weakly carcinogenic per se, but successfully cooperates with proinflammatory ETBF in experimental and likely human colorectal tumorigenesis [23].”
BackgroundThe crosstalk of intratumor bacteria and the tumor
Huang, J., Mao, Y., & Wang, L. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1273254 · Cited by 15
“Nutrient–fungi–host” tripartite interaction in cancer progression
Wu, D., Guan, Y., Li, C., Zheng, Q., Yin, Z., Wang, H., & Liu, N. (2024) · iMeta · doi:10.1002/imt2.170 · Cited by 15
“Hence, colonic mucosal biofilms may be triggers of CRC and have the potential to create a perfect environment of persistent inflammation for the promotion of colon carcinogenesis [33].”
BackgroundSelf-citationLiu, J., Qu, Y., Li, Y., Xu, Y.-L., Yan, Y.-F., & Qin, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27879 · Cited by 16
“These microorganisms within tumors are now recognized as crucial contributors to tumor development, drug resistance, and the tumor microenvironment [6, 7].”
BackgroundBiofilms 2018: a Diversity of Microbes and Mechanisms
Fuqua, C., Filloux, A., Ghigo, J., & Visick, K. L. (2019) · Journal of Bacteriology · doi:10.1128/jb.00118-19 · Cited by 14
“coli and enterotoxigenic Bacteroides fragilis; a mouse model designed to mimic this process exhibited accelerated tumor formation and mortality under conditions of cocolonization with the cancer-associated bacteria, potentially by fostering increased adherence of the problematic bacteria to the mucosa (66).”
BackgroundThe influence of the gastrointestinal microbiome on colorectal metastasis: a narrative review
Stakelum, Á., Zaborowski, A. M., Collins, D., & Winter, D. C. (2020) · Colorectal Disease · doi:10.1111/codi.14930 · Cited by 14
Ahn, J., Kang, M., Seo, Y., & Kim, H. (2022) · BMB Reports · doi:10.5483/bmbrep.2022-0182 · Cited by 18
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers
Liu, Z., Hong, L., & Ling, Z. (2023) · Cancer Medicine · doi:10.1002/cam4.6298 · Cited by 13
Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend
Wang, X., Sun, X., Chu, J., Sun, W., Yan, S., & Wang, Y. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03742-w · Cited by 14
“Similarly, enterotoxigenic B. fragilis acts as tumorigenic bacteria by increasing interleukin-17 and inducing colonic DNA damage in mice (Dejea et al. 2018).”
Chen, K., Yoshimura, T., Gong, W., Tian, C., Huang, J., Trinchieri, G., & Wang, J. (2021) · Journal of Cell Science · doi:10.1242/jcs.252148 · Cited by 18
“, 2017) as well as in CRC tissues (Arthur et al., 2012; Dejea et al., 2018).”
Lv, C., Abdullah, M., Su, C., Chen, W., Zhou, N., Cheng, Z., Chen, Y., Li, M., Simpson, K. W., Elsaadi, A. M., et al. (2025) · BMC Genomics · doi:10.1186/s12864-024-11198-x · Cited by 16
Weis, A. M., Bauer, K. M., Tang, W. W., Victor, E. S., Bell, R. S., Brown, D. G., Ekiz, H. A., Tran, V., Klag, K. A., Swanson, E. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116172 · Cited by 16
Sun, Z., Xu, M., Nie, L., Wang, C., Wu, J., Wang, W., Shi, S., & Song, H. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123804 · Cited by 16
Taoum, C., Carrier, G., Jarlier, M., Roche, G., Gagnière, J., Fiess, C., de Forges, H., Chevarin, C., Colombo, P., Barnich, N., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061527 · Cited by 14
Bacteria and macrophages in the tumor microenvironment
Xu, S. S., Xiong, Y., Fu, B., Guo, D. L., Sha, Z., Lin, X., & Wu, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1115556 · Cited by 14
“Colorectal cancer Firmicutes Lachnospiraceae Dejea et al. (2018), Yachida et al. (2019)”
BackgroundInfluentialCrosstalk between microbial biofilms in the gastrointestinal tract and chronic mucosa diseases
Wang, Y., Xu, S., He, Q., Sun, K., Wang, X., Zhang, X., Li, Y., & Zeng, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1151552 · Cited by 18
“coli in patients with familial adenomatous polyposis may enhance epithelial cells’ exposure to pks + coil and BFT and hasten the establishment of tumors due to the aggravation of interleukin-17 and DNA damage (Dejea et al., 2018).”
BackgroundColorectal cancer and microbiota: systematic review
Imanbayev, N. M., Iztleuov, Y. M., Bekmukhambetov, Y., Abdelazim, I. A., Donayeva, A., Amanzholkyzy, A., Zhumasheva, A., Imanbayeva, A., & Aslan, Y. (2024) · Gastroenterology Review · doi:10.5114/pg.2024.136228 · Cited by 17
“B. fragilis and E. coli produces local onco-toxins (i.e. B. fragilis toxin and colibactin) [31], which increased the tumour growth and mortality from CRCs in animal studies [31].”
Emerging implications of bacterial biofilm in cancer biology: Recent updates and major perspectives
Kushwaha, M., Nukala, V., Singh, A. K., Makharia, G. K., Mohan, A., Kumar, A., & Dalal, N. (2024) · Gut Microbes Reports · doi:10.1080/29933935.2024.2339270 · Cited by 16
“17 18–20 Since biofilm development represents both invasion efficacy and persistence, it is appropriate to evaluate pathogenicity using this factor.”
Colorectal cancer and inulin supplementation: the good, the bad, and the unhelpful
Oliero, M., Alaoui, A. A., McCartney, C., & Santos, M. M. (2023) · Gastroenterology report · doi:10.1093/gastro/goae058 · Cited by 12
Alves, A. M., Lecchi, C., Lopez, S., Stornetta, A., Mathai, P. P., Villalta, P. W., Ishii, S., Balskus, E. P., Balbo, S., & Khoruts, A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387877 · Cited by 12
“20 Degradation of protective mucus by enterotoxigenic B. fragilis can enhance contact of E. coli with the host epithelial cells and increase delivery of colibactin.”
BackgroundXu, W., Zhang, Y., Chen, D.-J., Huang, D., Zhao, Y., Hu, W., Lin, L., Liu, Y., Wang, S., Zeng, J., et al. (2024) · Gut Pathogens · doi:10.1186/s13099-024-00640-w · Cited by 13
“Recent studies have demonstrated that pro-tumorigenic gut bacteria are associated with CRC development, and it has been postulated that some of these bacteria could contribute to enhanced mutagenesis [11, 12, 30].”
BackgroundColibactin-induced damage in bacteria is cell contact independent
Lowry, E., & Mitchell, A. (2024) · mBio · doi:10.1128/mbio.01875-24 · Cited by 11
Chen, L., Yu, S., Shi, H., Chen, Y., Yang, T., Cao, W., Jiang, T., Wei, M., & Deng, Y. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202421288 · Cited by 15
Interfacial Morphodynamics of Proliferating Microbial Communities
Martínez-Calvo, A., Trenado-Yuste, C., Lee, H., Gore, J., Wingreen, N. S., & Datta, S. S. (2025) · Physical Review X · doi:10.1103/physrevx.15.011016 · Cited by 20
A bacterial mutational footprint in colorectal cancer genomes
Huber, A. R., Pleguezuelos‐Manzano, C., & Puschhof, J. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01273-5 · Cited by 13
Bacterial Toxins Are a Never-Ending Source of Surprises: From Natural Born Killers to Negotiators
Chiloeches, M. L., Bergonzini, A., & Frisan, T. (2021) · Toxins · doi:10.3390/toxins13060426 · Cited by 15
“fragilis has been demonstrated in two models of sporadic CRC (by administration of AOM) and hereditary CRC (the Apc Min∆716/+ mouse model), further corroborating the relevant role of colibactin in colon tumorigenesis [89].”
ResultKnippel, R. J., & Sears, C. L. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7062 · Cited by 14
“Namely, using the Apc mouse model, ETBF was identified to promote mucin degradation favoring the colonizationofpks(1)E coli and culminating in amultifaceted CEC assault resulting in tumor formation.(40) In additionalwork, humancolonbiofilmswereprocarcinogenic inmurinemodels(41) andmay localize tumorigenic bacteria and…”
BackgroundMethodSelf-citationPiazzesi, A., & Putignani, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.958346 · Cited by 14
“In a study using bacteria from humans, a tumor-prone mouse model co-infected with Escherichia coli and Bacteroides fragilis strains isolated from patients with familial adenomatous polyposis had a stronger pro-inflammatory response, greater tumor growth, and higher mortality rates than mice infected with either strain…”
BackgroundNAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5
Liang, X., Tang, Z., Zhang, Y., Sun, Y., & Wang, J. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022124 · Cited by 15
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
Sharma, S., Sharma, H., & Gogoi, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1277677 · Cited by 15
Profir, M., Roşu, O., Creţoiu, S. M., & Gașpar, B. S. (2024) · Microorganisms · doi:10.3390/microorganisms12050955 · Cited by 12
RETRACTED: Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer
Lin, S., Liu, Q., Wen, J., Bai, K., Guo, Y., & Wang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.570128 · Cited by 12
“The previous studies confirmed that IL-17 expression step by step increased along with colonic adenomas to cancer process, but it is not a prominent mark to diagnose the CRC because IL-17 is not associated with TNM parameters of the tumor (4, 5).”
BackgroundRetractedIntratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy
Yan, D., Yu, Y., Liang, C., Cui, Z., Shi, L., Li, G., & Ren, C. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02566-6 · Cited by 12
“For example, ETBF and pks + E. coli induce DNA damage by secreting toxins [127, 128].”
Optimum health and inhibition of cancer progression by microbiome and resveratrol
Stokes, J. A., III, Vinayak, S., Williams, J., Malik, S., Singh, R., Manne, U., Owonikoko, T. K., & Mishra, M. K. (2021) · Frontiers in bioscience · doi:10.2741/4904 · Cited by 11
“The pathogenicity of both bacterial strains resulted in increased interleukin-17 in the colon and DNA damage in colonic epithelial cells as compared to mice with either bacterial strain alone (53).”
BackgroundIntratumoral microorganisms in tumors of the digestive system
Xuan, M., Gu, X., Liu, Y., Li, Y., Li, Y., Huang, D., Li, J., & Xue, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01425-5 · Cited by 13
“In addition to F. nucleatum , other bacteria may also influence the development, progression, and clinical manifestations of CRC [62, 63, 68, 77].”
BackgroundKeystone pathobionts associated with colorectal cancer promote oncogenic reprograming
Jones, J. P., Shi, Q., Nath, R. R., & Brito, I. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297897 · Cited by 14
Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer
Ayabe, R. I., & White, M. G. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904152 · Cited by 14
Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
Ke, X., Jiang, S., Wei, Q., Sun, M., Sun, H., Pang, M., Liu, M., Sun, L., Yang, H., & Mao, Y. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.1039 · Cited by 14
Chang, Y., Long, M., Shan, H., Liu, L., Zhong, S., & Luo, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104629 · Cited by 14
Verma, M., Randhawa, S., Bathla, M., Teji, N., & Acharya, A. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02409e · Cited by 16
Spatial self-organization of confined bacterial suspensions
Hokmabad, B. V., Martínez-Calvo, A., Corte, S. G. L., & Datta, S. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503983122 · Cited by 16
Modeling colorectal cancers using multidimensional organoids
Sayed, I. M., El‐Hafeez, A. A. A., Maity, P. P., Das, S., & Ghosh, P. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.005 · Cited by 13
Progress of gut microbiome and its metabolomics in early screening of colorectal cancer
Zhou, L., Jiang, Z., Zhang, Z., Xing, J., Wang, D., & Tang, D. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03097-6 · Cited by 12
“They cause cellular translation silencing through c-Myc/miR-20a-5p and binding to the SENP1 mRNA 3’UTR [46, 47].”
BackgroundTakeda, K., Koi, M., Okita, Y., Sajibu, S., Keku, T. O., & Carethers, J. M. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0179 · Cited by 13
Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development
Neff, S. L., Hampton, T. H., Koeppen, K., Sarkar, S., Latario, C. J., Ross, B. D., & Stanton, B. A. (2023) · mSystems · doi:10.1128/msystems.00653-23 · Cited by 11
“While the mucosal layer acts to buffer the epithelium from the bulk of the gut microbiota, B. fragilis can colonize colonic crypts and even form polymicrobial biofilms at sites of colonic polyp formation (90, 91) .”
BackgroundGe, Z., Feng, Y., Sheh, A., Muthupalani, S., Gong, G., Chawanthayatham, S., Essigmann, J. M., & Fox, J. G. (2019) · International Journal of Cancer · doi:10.1002/ijc.32332 · Cited by 14
“coli in the colonic biofilms of patients with familial adenomatous polyposis and Apc mice is enriched by concurrent colonization of Bacteroides fragilis.(48) In the current study, H.”
BackgroundLactobacillus reuteri—an old acquaintance takes on a new task in colorectal tumor surveillance
Watschinger, C., & Moschen, A. R. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.01.014 · Cited by 12
Acromegaly is associated with a distinct oral and gut microbiota
Şahin, S., Gündoğdu, A., Nalbantoglu, U., Kadıoğlu, P., Karaca, Z., Hacıoğlu, A., Urhan, M. E., Ünlühızarcı, K., Demir, A. N., Hora, M., et al. (2022) · Pituitary · doi:10.1007/s11102-022-01223-1 · Cited by 11
“found that Bacteroides fragilis and Escherichia coli predominated in the resected tissue of patients with familial adenomatous polyposis [36].”
BackgroundQiao, Z., Han, J., Feng, H., Zheng, H., Wu, J., Gao, C., Yang, M., You, C., Liu, Z., & Wu, Z. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03292 · Cited by 10
“These diseases include autism, Parkinson’s disease and cancer (Hsiao et al., 2013; Buffington et al., 2016; Thaiss et al., 2016; Yu et al., 2017; Chung et al., 2018; Dejea et al., 2018; Routy et al., 2018; Tilg et al., 2018).”
BackgroundClinically adaptable polymer enables simultaneous spatial analysis of colonic tissues and biofilms
Macedonia, M. C., Drewes, J. L., Markham, N. O., Simmons, A. J., Roland, J. T., Vega, P. N., Scurrah, C. R., Coffey, R. J., Shrubsole, M. J., Sears, C. L., et al. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-00143-x · Cited by 12
Self-citationMicrobial metabolites damage DNA
Puschhof, J., & Sears, C. L. (2022) · Science · doi:10.1126/science.ade6952 · Cited by 11
Self-citationAbahussin, H. M., Alotaibi, M. S., Alhazzaa, O. A., Alotaibi, A. G., Alsaab, S. M., Aljawini, N., & Alawad, A. O. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00788-z · Cited by 18
Adade, E. E., Lakhen, K. A., Lemus, A. A., & Valm, A. M. (2021) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2021.04.005 · Cited by 12
Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer
Lee, J. H., Wickes, B. L., Fu, J., Brockman, N. E., Garg, H., Jobin, C., Johnson‐Pais, T. L., Leach, R. J., Lai, Z., & Liss, M. A. (2023) · The Prostate · doi:10.1002/pros.24500 · Cited by 11
“coli]).(6) For example, colibactin is a bacterially produced toxin implicated as a cause of colon cancer.”
BackgroundYang, S., Hao, S., Ye, H., & Zhang, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1083987 · Cited by 10
“With a stringent screening process based on Bradford’s law, the WoSCC’s Science Citation Index Expanded (SCI-E) highlights the most reputable and noteworthy academic work in natural science (Yang S. et al., 2022; Zyoud et al., 2022).”
BackgroundInfluentialArchaea influence composition of endoscopically visible ileocolonic biofilms
Orgler, E., Baumgartner, M., Duller, S., Kumptisch, C., Hausmann, B., Moser, D., Khare, V., Lang, M., Köcher, T., Frick, A. P., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2359500 · Cited by 13
Oliero, M., Cuisiniere, T., Ajayi, A. S., Gerkins, C., Hajjar, R., Fragoso, G., Calvé, A., Rendos, H. V., Mathieu‐Denoncourt, A., Dagbert, F., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0355 · Cited by 12
“Colibactin-producing bacteria are present in 4.35% to 68% of both healthy individuals and patients with colorectal cancer (35, 36).”
BackgroundInfluentialMicrobiome—Stealth Regulator of Breast Homeostasis and Cancer Metastasis
Furuta, S. (2024) · Cancers · doi:10.3390/cancers16173040 · Cited by 10
Hwang, S., Jo, M., Hong, J.-E., Kim, W.-S., Kang, D.-H., Yoo, S.-H., Kang, K., & Rhee, K. (2024) · Toxins · doi:10.3390/toxins16090403 · Cited by 13
Ren, A., Zhou, Y., Xu, Z., Jia, T., & Yang, L. (2024) · Current Medicine · doi:10.1007/s44194-024-00039-4 · Cited by 15
“Disruption of a healthy mucosal biofilm leads to the proximity or direct contact of pathogenic invasive biofilms with colonic epithelial cells, thereby causing inflammation (Dejea et al. 2018).”
The metabolic and immunomodulatory functions of Bacteroides fragilis; a next-generation probiotic?
Roustapoor, R., Abdi, E., Khabbaz, A., & Abdi, A. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100137 · Cited by 12
Lactylation: A new direction for tumor-targeted therapy
Deng, D., Luo, Y., Hong, Y., Ren, X., Zu, X., & Feng, J. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189399 · Cited by 15
Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Yang, S., Wang, Z., Fang, C., Yang, M., Khawaled, S., Bonanno, S. L., Joshi, N. S., Wei, Y., Zhang, K., Márquez-Pellegrin, V., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02177-3 · Cited by 15
“Of note, colibactin-producing pks ⁺ bacteria are major contributors to early-onset colorectal cancer (EOCRC) by inducing the earliest driver mutations in adenomatous polyposis coli (APC) during the first decade of life—well before the clinical onset of disease 48 .”
InfluentialDeciphering the Colorectal Cancer Gut Microbiota: Association vs. Causality
Bridges, K. M., Greiner, K. A., & Umar, S. (2019) · Current Colorectal Cancer Reports · doi:10.1007/s11888-019-00431-5 · Cited by 11
Bartonella henselae Detected in Malignant Melanoma, a Preliminary Study
Ericson, M. E., Breitschwerdt, E. B., Reicherter, P., Maxwell, C., Maggi, R. G., Melvin, R. G., Maluki, A. H., Bradley, J. M., Miller, J. C., Simmons, G. E., et al. (2021) · Pathogens · doi:10.3390/pathogens10030326 · Cited by 12
“More recent studies suggest that Streptococcus bovis is associated with colorectal cancer [8,9].”
ResultAitchison, A., Pearson, J. F., Purcell, R. V., Frizelle, F., & Keenan, J. I. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269541 · Cited by 10
“coli colibactin toxin may work together to promote colon cancer [10].”
BackgroundImprove the Colorectal Cancer Diagnosis Using Gut Microbiome Data
Zhou, Y., & Sun, G. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.921945 · Cited by 12
Advances in Mapping Tumor Progression from Precancer Atlases
Chen, Z., & Lau, K. S. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0473 · Cited by 10
Guglielmo, M. D. D., Franke, K., Cox, C. L., & Crowgey, E. L. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2019.100057 · Cited by 10
“Biofilms can both contribute to disease and form barriers important for immune function [24].”
BackgroundWatanabe, D., Murakami, H., Ohno, H., Tanisawa, K., Konishi, K., Todoroki-Mori, K., Tsunematsu, Y., Sato, M., Ogata, Y., Miyoshi, N., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02255-6 · Cited by 10
“coli isolated from the colonic epithelium has been reported to be higher in patients with familial adenomatous polyposis [22], inflammatory bowel disease [23], and CRC [22] than in healthy individuals.”
Lou, Y., Song, M., Han, M., Zhong, J., Tian, X., Ren, Y., Song, Y., Duan, L., Zhao, P., Song, X., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0666 · Cited by 11
Self-citationGuragain, M., Schmidt, J. W., Kalchayanand, N., Dickey, A. M., & Bosilevac, J. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-09274-x · Cited by 10
Dai, J., Fu, Y., Zhong, X., Cen, W., Ye, M.-F., Chen, X.-H., Pan, Y., & Ye, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.916565 · Cited by 12
“ETBF positivity was found to be more frequent in patients with sporadic premalignant lesions (39) and familial adenomatous polyposis (40) than in their respective controls.”
BackgroundEffect of gut microbiota on colorectal cancer progression and treatment
Alasiri, G. A. (2022) · Saudi Medical Journal · doi:10.15537/smj.2022.43.12.20220367 · Cited by 12
Kwarteng, A., Wireko, S., Asiedu, S. O., Kini, P., Aglomasa, B. C., Amewu, E. K. A., Asiedu, E., Boahen, K. G., Amato, K. R., & Obiri‐Yeboah, D. (2022) · Scientific African · doi:10.1016/j.sciaf.2022.e01237 · Cited by 9
Colorectal Cancer and Microbiota Modulation for Clinical Use. A Systematic Review
Madrigal‐Matute, J., & Bañón-Escandell, S. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2108468 · Cited by 9
Marin-Dett, F. H., Campanella, J. E. M., Trovatti, E., Bertolini, M. C., Vergani, C. E., & Barbugli, P. A. (2022) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2022-0319 · Cited by 10
Deng, J., Huang, Y., Yu, K., Luo, H., Zhou, D., & Li, D. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106784 · Cited by 10
Microbial Biomarkers in Liquid Biopsy for Cancer: An Overview and Future Directions
Luo, F., Wang, X., Ye, C., & Sun, H. (2024) · Cancer Control · doi:10.1177/10732748241292019 · Cited by 14
Biodiversity and biogeography of the multi-kingdom cancer microbiome
Dohlman, A. B., Mjelle, R., Wood, H. M., Jiang, K., Shumate, A., Lee, I., Piccinno, G., Serna, G., Yakubu, A.-R., Nuciforo, P. G., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.015 · Cited by 16
Role of Gut Microbiome in Immune Regulation and Immune Checkpoint Therapy of Colorectal Cancer
Shi, L., Xu, Y., & Feng, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07689-0 · Cited by 9
“Additionally, independent studies have reported that Fusobacterium nucleatum and Bacteroides fragilis may inhibit the antitumor response of T cells and increase inflammation in CRC mouse models [61, 62].”
ResultHow is gut microbiome of patients with familial adenomatous polyposis different from healthy people?
Kim, J. H., Kim, Y. J., Oh, G. M., Jung, W., & Park, S. J. (2022) · Medicine · doi:10.1097/md.0000000000032194 · Cited by 9
The Influence of the Microbiome on Metastatic Colorectal Cancer
Cass, S. H., & White, M. G. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1760864 · Cited by 9
Chang, Y., Ou, Q., Zhou, C., Liu, J., & Zhang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1182006 · Cited by 13
“The mechanism primarily includes three aspects: firstly, it causes DNA damage in intestinal epithelial cells by producing toxins (Dejea et al., 2018; Li et al., 2019; Chen et al., 2022) secondly, it causes metabolic disorders in the body by forming secondary metabolites (Taira et al.”
BackgroundBahuguna, A., & Dubey, S. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188956 · Cited by 11
Systematic review on the role of the gut microbiota in tumors and their treatment
Shi, Y., Li, X., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355387 · Cited by 14
Gut Microbiome and Colon Cancer: A Plausible Explanation for Dietary Contributions to Cancer
Nelson, H., & Chia, N. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.05.003 · Cited by 9
Microbiome and colorectal cancer: A review of the past, present, and future
Johns, M. S., & Petrelli, N. J. (2021) · Surgical Oncology · doi:10.1016/j.suronc.2021.101560 · Cited by 10
Wang, H., Chen, K., Ning, M., Wang, X., Wang, Z., Yue, Y., Yuan, Y., & Yue, T. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200474 · Cited by 9
Self-citationWang, F., Wu, J., Wang, Y., Jin, Y., Jiang, X., Qiu, Z., Yan, Q., Liu, Y., Qi, X., Ge, X., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000074 · Cited by 10
Peptostreptococcus anaerobius is a potential diagnostic biomarker of colorectal cancer
Zhang, Y., Fan, K., Li, L., He, J., & Sun, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.10.36 · Cited by 9
“They are able to activate cancer-associated pathways and thus accelerate the development of CRC (4,5).”
Recent progress in nanomaterials for bacteria-related tumor therapy
Zhang, F., Wang, S., Yang, S., Ma, F., & Gao, H. (2024) · Biomaterials Science · doi:10.1039/d3bm01952g · Cited by 10
Microbiota-associated mechanisms in colorectal cancer
González, A., Fullaondo, A., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.05.002 · Cited by 8
Intratumor microbiota and colorectal cancer: Comprehensive and lucid review
Zong, Z., Zeng, W., Li, Y., Wang, M., Cao, Y., Cheng, X., Jin, Z., Mao, S., & Zhu, X. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.07 · Cited by 9
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut
Spiga, L., Fansler, R. T., Wu, Y., Grote, A., Langford-Butler, M., Miller, A. K., Neal, M. J., Hale, O. F., Singla, D., Calcutt, M. W., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.012 · Cited by 11
Self-citationWorking together: gut microbe-microbe interactions shape host inflammation
Lawing, A., & Bleich, R. M. (2025) · Infection and Immunity · doi:10.1128/iai.00512-24 · Cited by 9
Wang, J., Ouyang, S., Lin, G., Li, D., Ding, B., Chen, Y., Tong, B., Ouyang, T., Xu, H., & Wu, W. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.09.006 · Cited by 10
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.